New research from UCL reveals alarming levels of tooth decay in adults in England, highlighting the need for improved dental care and public health initiatives.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
Amidst a stark rise in US syphilis cases, researchers have secured a $2.7 million NIH grant to develop the first comprehensive, rapid test for active infection that aims to deliver accurate results within 10 minutes.
Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
Research from the University of Liverpool indicates that administering antibiotics alongside antimicrobials could lower death rates from malaria and meningitis.
The first comprehensive analysis of three major lung diseases, asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), across England, Wales, Scotland, and Northern Ireland has been published.
